Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Revenue

Janux Therapeutics had revenue of $10.27M in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to $24.00M, up 5,366.97% year-over-year. In the year 2025, Janux Therapeutics had annual revenue of $10.00M, down -5.55%.

• Revenue (ttm): $24.00M
• Revenue Growth: +5,366.97%
• P/S Ratio: 43.33
• Revenue / Employee: $212,389
• Employees: 113
• Market Cap: 1.03B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.00M	-588.00K	-5.55%
Dec 31, 2024	10.59M	2.51M	30.99%
Dec 31, 2023	8.08M	-529.00K	-6.14%
Dec 31, 2022	8.61M	4.98M	136.79%
Dec 31, 2021	3.64M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 15, 2026

Data Sources Report a data error